|
|
|
|
First Geoclock Product, Lodotra, Approved in Europe
-- SkyePharma PLC (LSE: SKP) today announces that its partner Nitec has received the Final Assessment Report from the German BfArM (Bundesinstitut fr Arzneimittel und Medizinprodukte), concluding that Lodotra is approvable for the treatment...
|
|
|
Skyepharma PLC announces European Product Approval
First GeoclockTM Product, LodotraTM, Approved in Europe LONDON, UK, 7 January 2009 -- SkyePharma PLC (LSE: SKP) today announces that its partner Nitec has received the Final Assessment Report from the German BfArM (Bundesinstitut fur...
|
|
|
Skyepharma PLC announces European Product Approval
-- First GeoclockTM Product, LodotraTM, Approved in Europe LONDON, UK, 7 January 2009 -- SkyePharma PLC (SKP) today announces that its partner Nitec has received the Final Assessment Report from the German BfArM (Bundesinstitut fur...
|
|
|
Skyepharma PLC announces European Product Approval
-- First GeoclockTM Product, LodotraTM, Approved in Europe LONDON, UK, 7 January 2009 -- SkyePharma PLC (LSE: SKP) today announces that its partner Nitec has received the Final Assessment Report from the German BfArM (Bundesinstitut fur...
|
|
|
Skyepharma PLC announces European Product Approval
(MARKET WIRE via COMTEX) -- First GeoclockTM Product, LodotraTM, Approved in Europe LONDON, UK, 7 January 2009 -- SkyePharma PLC (UK:SKP: news , chart , profile ) today announces that its partner Nitec has received the Final Assessment...
|
|
|
Skyepharma PLC announces European Product Approval
First GeoclockTM Product, LodotraTM, Approved in Europe LONDON, UK, 7 January 2009 -- SkyePharma PLC (LSE: SKP) today announces that its partner Nitec has received the Final Assessment Report from the German BfArM (Bundesinstitut fur...
|
|
|
Skyepharma PLC announces European Product Approval
Skyepharma ADR (SKYE) Stock Quote, Chart, News, Add to Watchlist All Market Wire news First GeoclockTM Product, LodotraTM, Approved in Europe LONDON, UK, 7 January 2009 -- SkyePharma PLC (LSE: SKP) today announces that its partner Nitec has...
|
|
|
Skyepharma PLC announces European Product Approval
First GeoclockTM Product, LodotraTM, Approved in Europe LONDON, UK, 7 January 2009 -- SkyePharma PLC (LSE: SKP) today announces that its partner Nitec has received the Final Assessment Report from the German BfArM (Bundesinstitut fur...
|
|
|
Skyepharma PLC announces European Product Approval
First GeoclockTM Product, LodotraTM, Approved in Europe LONDON, UK, 7 January 2009 -- SkyePharma PLC (LSE:SKP.L - News) today announces that its partner Nitec has received the Final Assessment Report from the German BfArM (Bundesinstitut fur...
|
|
|
Skyepharma PLC announces European Product Approval
-- First GeoclockTM Product, LodotraTM, Approved in Europe LONDON, UK, 7 January 2009 -- SkyePharma PLC (LSE:SKP.L - News) today announces that its partner Nitec has received the Final Assessment Report from the German BfArM (Bundesinstitut...
|
|
|
Skyepharma PLC announces European Product Approval
First GeoclockTM Product, LodotraTM, Approved in Europe LONDON, UK, 7 January 2009 -- SkyePharma PLC (LSE: SKP) today announces that its partner Nitec has received the Final Assessment Report from the German BfArM (Bundesinstitut fur...
|
|
|
Nitec Pharmas New Rheumatoid Arthritis Treatment, Lodotra, Recommended For European Regulatory Approval
Nitec Pharma AG (Nitec or Nitec Pharma), a Switzerland-based specialty pharma company focused on the development and commercialization of medicines to treat chronic inflammation and pain-related diseases, today announced that its lead...
|
|
|
Skyepharma PLC: Skyepharma PLC announces European Product Approval
announces European Product Approval SOURCE: SkyePharma PLC Jan 07, 2009 02:00 ET Skyepharma PLC announces European Product Approval Highlighted Links LONDON--(Marketwire - January 7, 2009) - First GeoclockTM Product, LodotraTM, Approved in...
|
|
|
Night time release pill gains EU approval
Related topics: Materials & Formulation, Drug delivery systems Nitec has received approval in Europe for its rheumatoid arthritis treatment Lodotra making it the first product using SkyePharmas propriety drug delivery technology...
|
|
|
ACADIA Pharmaceuticals Awarded Grant from The Michael J. Fox Foundation for the Development of Novel ER-beta A
The award by The Michael J.Fox Foundation for Parkinson's Research provides important recognition for ACADIA's ER-beta program for the treatment of Parkinson's disease and further validates the quality and productivity of our drug...
|
|
|
Study backs deep brain stimulation for Parkinson's
WASHINGTON (Reuters) - Deep brain stimulation dramatically improves Parkinson's disease symptoms such as trembling and slowness of movement, offering hope to many with the incurable ailment, researchers said on Tuesday.Six months of deep...
|
|
|
Nitec PharmaEURs New Rheumatoid Arthritis Treatment, Lodotra, Recommended For European Regulatory Approval
Nitec Pharma AG (Nitec or Nitec Pharma), a Switzerland-based specialty pharma company focused on the development and commercialization of medicines to treat chronic inflammation and pain-related diseases, today announced that its lead...
|
|
|
Skyepharma PLC announces European Product Approval
LONDON, January 7 / MARKET WIRE/ -- First GeoclockTM Product, LodotraTM, Approved in Europe LONDON, UK, 7 January 2009 -- SkyePharma PLC (LSE: SKP) today announces that its partner Nitec has received the Final Assessment Report from the...
|
|
|
Arthritis decision cheers SkyePharma
German regulators have approved SkyePharmas rheumatoid arthritis treatment, Lodotra, for use in 15 European countries.The fully listed company says Nitec Pharma, its Swiss partner in developing Lodotra, has received a final assessment...
|
|
|
Best Treatment for Parkinson's Disease
Related Topics: Richard Seeger | Bruce Hensel 0 Comments Post a Comment Share Del.icio.us MySpace Digg Facebook What is the best treatment for parkinson disease?A new study provides the surprising answer, Dr Bruce Hensel reported? ...
|
|
|
Study backs deep brain stimulation for Parkinson's
WASHINGTON (Reuters) - Deep brain stimulation dramatically improves Parkinson's disease symptoms such as trembling and slowness of movement, offering hope to many with the incurable ailment, researchers said on Tuesday.Six months of deep...
|
|
|
Study Backs Deep Brain Stimulation For Parkinson's
Deep brain stimulation dramatically improves Parkinson's disease symptoms such as trembling and slowness of movement, offering hope to many with the incurable ailment, researchers said on Tuesday.Six months of deep brain stimulation with...
|
|
|
A Comparison Between a Retrograde Interference Screw, Suture Button, and Combined Fixation on the Tibial Side
Background: Effective soft tissue graft fixation to the tibial tunnel in all-inside anterior cruciate ligament reconstructions has been reported to be a problem and may lead to retrograde pullout at ultimate load testing.Hypothesis: A...
|
|
|
Study backs deep brain stimulation for Parkinson's
By Will Dunham WASHINGTON (Reuters) - Deep brain stimulation dramatically improves Parkinson's disease symptoms such as trembling and slowness of movement, offering hope to many with the incurable ailment, researchers said on Tuesday.Six...
|
|
|
The Effect of Repair of the Lacertus Fibrosus on Distal Biceps Tendon Repairs: A Biomechanical, Functional, an
A Biomechanical, Functional, and Anatomic Study Joshua Landa, MD*,, Sachin Bhandari, Eric J.Strauss, MD, Peter S. Walker, PhD and Robert J. Meislin, MD Department of Orthopaedic Surgery, New York University Hospital for Joint Diseases...
|
